Equity research analysts covering HNST maintain a consensus Buy rating, supported by improved profitability metrics and successful cost-reduction strategies. Consensus 12-month average price targets hover around $4.82, reflecting cautious optimism as the company proves its ability to sustain positive EBITDA and gross margin expansion in a competitive retail market.